| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA990008040490403321 |
|
|
Autore |
Pagliani, Maria Luigia |
|
|
Titolo |
Piacenza : forma e urbanistica / Maria Luigia Pagliani |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Roma : L'Erma di Bretschneider, 1991 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
111 p., [2] c. di tav. ripieg. : ill ; 27 cm + 1 c. geogr |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Locazione |
|
|
|
|
|
|
Collocazione |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
2. |
Record Nr. |
UNINA9910141290003321 |
|
|
Titolo |
Pharmaceutical biotechnology : drug discovery and clinical applications / / edited by Oliver Kayser and Heribert Warzecha |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Weinheim, : Wiley-Blackwell, 2012 |
|
|
|
|
|
|
|
ISBN |
|
9786613640307 |
9781280663376 |
1280663375 |
9783527651269 |
3527651268 |
9783527632909 |
3527632905 |
9783527651252 |
352765125X |
|
|
|
|
|
|
|
|
Edizione |
[2nd., completely rev. and greatly enl. ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (677 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
KayserOliver |
WarzechaHeribert |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical biotechnology |
|
|
|
|
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
pt. 1. Concepts and methods for recombinant drug production -- pt. 2. Bringing the drug into action : from downstreaming to approval -- pt. 3. Vaccines -- pt. 4. Recent applications in pharmaceutical biotechnology. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This second edition of a very successful book is thoroughly updated with existing chapters completely rewritten while the content has more than doubled from 16 to 36 chapters. As with the first edition, the focus is on industrial pharmaceutical research, written by a team of industry experts from around the world, while quality and safety management, drug approval and regulation, patenting issues, and biotechnology fundamentals are also covered. In addition, this new edition now not only includes biotech drug development but also the use of biopharmaceuticals in diagnostics and vaccinations. < |
|
|
|
|
|
|
|
| |